IPP Bureau
Elekta and IAEA partner to improve access to cancer care in underserved countries
By IPP Bureau - September 01, 2023
Dr. Laurent Leksell, Elekta’s Founder and Chairman of the Board, and IAEA’s Director General, Dr. Rafael Mariano Grossi meet in Stockholm to discuss reducing the global cancer burden
Pfizer and BioNTech receive positive CHMP opinion for Omicron XBB.1.5-adapted COVID-19 vaccine
By IPP Bureau - September 01, 2023
The updated COVID-19 vaccine is tailored to the Omicron XBB.1.5 sublineage of SARS-CoV-2 and is recommended for individuals 6 months of age and older
Strides receives USFDA approval for Mycophenolate Mofetil for oral suspension
By IPP Bureau - August 31, 2023
The approval bolsters the company's Mycophenolate Mofetil portfolio
Lupin receives USFDA approval for Pirfenidone Capsules
By IPP Bureau - August 31, 2023
Pirfenidone Capsules had estimated annual sales of USD 95 million in the US
Unichem receives ANDA approval for Prasugrel Tablets
By IPP Bureau - August 31, 2023
Prasugrel tablets are indicated to reduce the rate of thrombotic CV events
Lupin launches propranolol capsules to improve heart health in Canada
By IPP Bureau - August 31, 2023
Propranolol LA is a generic equivalent of Inderal LA
Ajanta Pharma receives USFDA for Topiramate Extended Release Capsules
By IPP Bureau - August 31, 2023
Topiramate is the generic version of Supernus Pharmaceuticals’ Trokendi XR
Mankind Pharma launches 120 premium DMF quality drugs for Indian Patients
By IPP Bureau - August 30, 2023
Mankind Pharma's initiative aims to ensure universal access to medicines of international calibre
GarbhaGudi IVF Centre launches ‘Ghar Ghar Garbhagudi' campaign
By IPP Bureau - August 30, 2023
The three-week travel campaign is aimed at spreading awareness about infertility and making Karnataka infertility-free
European Commission approves Keytruda plus Trastuzumab and chemotherapy as first-line treatment for GEJ
By IPP Bureau - August 30, 2023
KEYTRUDA is the first immunotherapy approved in the EU for the first-line treatment of this patient population
Novo Nordisk, Eli Lilly record growth in Q2 driven by obesity, diabetes drug sales
By IPP Bureau - August 30, 2023
Novo Nordisk’s GLP-1 Ozempic has reported a YoY increase in revenue from $2.1 billion to $3.2 billion
CK Birla Hospital signs MoU Intuitive for robotic-assisted surgery
By IPP Bureau - August 30, 2023
Hospital joins with Intuitive to install da Vinci systems to support enhanced healthcare delivery and patient outcomes across India
BlueRock’s Phase I study with bemdaneprocel in patients with Parkinson’s disease meets primary endpoint
By IPP Bureau - August 29, 2023
Investigational cellular therapy, bemdaneprocel (BRT-DA01), was well tolerated with no major safety issues in all 12 participants in low dose and high dose cohorts through one year / At one-year
Bayer appoints Dr. Juergen Eckhardt as new Head of Pharmaceuticals Business Development & Licensing/Open Innovation
By IPP Bureau - August 29, 2023
Juergen Eckhardt joined Bayer in 2016 to help start Leaps by Bayer
Thermo Fisher Scientific launches ‘Made in India’ TSV Series lab refrigerators and freezers
By IPP Bureau - August 29, 2023
The refrigerators and freezers are the latest offering in Thermo Fisher’s industry-leading portfolio of smart lab solutions
